Home
About us
News
Products
Innovation
CMO/CDMO Services
Contact
中文
undefined
Vice Governor of Hunan Province visited Jiudian Pharmaceutical
On the morning of April 1, Mr. Wang Junshou, Vice Governor of Hunan Province, led a research team to Jiudian Pharmaceutical for an inspection. The visit aimed to gain an in-depth understanding of the company's development and guide high-quality development work. Mr. Meng, a first-level inspector of the Provincial Government Office, Mr. Lin, deputy director of the Provincial Party Committee's Financial Office, and Mr. Ouyang, director of the Provincial Drug Administration, participated in the research. Mr. Zhu, chairman of Jiudian Pharmaceutical, Ms. Zeng, deputy general manager and secretary of the board of directors, and Mr. Xiang, director of the production center, accompanied the research.
03
2025
/
04
"No Regrets in Every Move, Endless Joy in Chess" ——Hongyang Labor Union's March chess competition concluded successfully
To promote traditional Chinese culture and enrichemployees' spare time, Jiudian Hongyang Labor Union successfully held a unique Chinese chess and Gobang competition in March. The competition ended successfully on March 26, attracting 59 chess enthusiasts from various departments. The participants strategized on the chessboard, showing a wonderful collision of wisdom and strategy,creating an electrifying atmosphere filled with excitement.
29
Jiudian Pharmacy and Jinying Jiahe reached a strategic cooperation to jointly develop the comprehensive health industry
On the afternoon of March 17, Mr. Zheng, general manager of Jiudian Pharmacy, and Ms. Ou, director of Hunan Jinying Jiahe Health Consulting Co., Ltd., signed an in-depth strategic cooperation agreement on behalf of both companies. The two parties will carry out in-depth collaboration around private-domain health products, training and channel resource integration.
18
Jiudian Hongyang's pharmaceutical excipient Crotamiton approved for marketing
Recently, the registration status of Jiudian Hongyang's pharmaceutical excipient Crotamiton (F20220000469) achieved a registration status changed from "I" to "A" at the CDE of the NMPA, and it successfully passed the review and was approved for marketing.
14
Jiudian Pharmaceutical successfully passed the on-site inspection of health food production license
The Hunan Provincial Market Supervision Administration organized an expert team to conduct a strict on-site inspection of Jiudian Pharmaceutical's application for expansion of health food production license. After a comprehensive review, the expert team announced that the inspection was successfully passed.
06
Jiudian Hongyang's API Polaprezinc approved for marketing
Recently, good news came that Jiudian Hongyang's API Polaprezinc (Y20230000678) was registered as "A" in the Center for Drug Evaluation (CDE) of the NMPA and has been successfully approved for marketing.
Jiudian's new antipsychotic drug, Ziprasidone Hydrochloride Capsules, approved for marketing
Recently, the new antipsychotic drug Ziprasidone Hydrochloride Capsules of Jiudian Pharmaceuticals were approved for marketing by the National Medical Products Administration. Jiudian Pharmaceuticals has become the first company in China to pass the consistency evaluation of this product. So far, the company has 33 products that have passed the consistency evaluation.
26
02
Jiudian successfully passed the on-site inspection for drug registration
From February 17 to 21, the expert group of the Greater Bay Area Center for Drug Review and Inspection of the NMPA visited the Jiudian Production Center to conduct on-site inspections of drug registration. After a comprehensive review, the company's R&D system and production quality management system were highly recognized by the inspection team.Two products, Simethicone Emulsion and Pentoxifylline Sustained-Release Tablets, successfully passed the inspection.
24